ask="100.00"
ask_size="200"
average_daily_volume="463985"
bid="55.00"
bid_size="9900"
book_value="11.49"
change="-3.34"
change_from_200_day_moving_average="13.97"
change_from_50_day_moving_average="11.24"
change_from_52_week_high="-5.89"
change_From_52_week_low="38.94"
change_in_percent="-3.76%"
close="85.46"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-6.21"
ebitda="-244.58M"
eps_estimate_current_year="-7.11"
eps_estimate_next_quarter="-1.78"
eps_estimate_next_year="-6.45"
ex_dividend_date="N/A"
float_shares="38556000"
high="91.35"
high_52_weeks="91.35"
last_trade_date="3/2/2017"
last_trade_price="85.46"
last_trade_size="20270"
last_trade_time="4:00pm"
low="85.22"
low_52_weeks="46.52"
market_capitalization="3.57B"
moving_average_200_day="71.49"
moving_average_50_day="74.22"
name="Ultragenyx Pharmaceutical Inc."
notes="N/A"
one_year_target_price="93.71"
open="89.00"
pe_ratio="N/A"
peg_ratio="-0.42"
percent_change_from_200_day_moving_average="+19.54%"
percent_change_from_50_day_moving_average="+15.15%"
percent_change_from_52_week_high="-6.44%"
percent_change_from_52_week_low="+83.71%"
previous_close="88.80"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="7.73"
price_per_sales="27859.17"
revenue="133000.00"
shares_outstanding="41726000"
short_ratio="15.47"
stock_exchange="NMS"
symbol="RARE"
volume="533299"
weeks_range_52="46.52 - 91.35"
